• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗焦虑药物奥匹哌醇对σ结合位点的特异性调节。

Specific modulation of sigma binding sites by the anxiolytic drug opipramol.

作者信息

Holoubek G, Müller W E

机构信息

Department of Pharmacology, Biocenter University Frankfurt, Frankfurt, Germany.

出版信息

J Neural Transm (Vienna). 2003 Oct;110(10):1169-79. doi: 10.1007/s00702-003-0019-5.

DOI:10.1007/s00702-003-0019-5
PMID:14523629
Abstract

The atypical anxiolytic and antidepressive drug opipramol binds with high affinity to sigma1 and somewhat lower affinity to sigma2 sites. After subchronic treatment, opipramol significantly down-regulated sigma2 but not sigma1 sites. This effect was not seen for imipramine, citalopram, and reboxetine under similar conditions. On the other hand, only imipramine reduced the number of sigma1 sites. It is suggested that effects at sigma2 sites are involved in the anxiolytic properties of opipramol.

摘要

非典型抗焦虑和抗抑郁药物奥匹哌醇与σ1位点具有高亲和力,与σ2位点的亲和力略低。亚慢性治疗后,奥匹哌醇显著下调σ2位点,但对σ1位点无此作用。在类似条件下,丙咪嗪、西酞普兰和瑞波西汀未出现这种效应。另一方面,只有丙咪嗪减少了σ1位点的数量。有人提出,对σ2位点的作用与奥匹哌醇的抗焦虑特性有关。

相似文献

1
Specific modulation of sigma binding sites by the anxiolytic drug opipramol.抗焦虑药物奥匹哌醇对σ结合位点的特异性调节。
J Neural Transm (Vienna). 2003 Oct;110(10):1169-79. doi: 10.1007/s00702-003-0019-5.
2
Neuropharmacology of the anxiolytic drug opipramol, a sigma site ligand.抗焦虑药物奥匹哌醇的神经药理学,一种西格玛位点配体。
Pharmacopsychiatry. 2004 Nov;37 Suppl 3:S189-97. doi: 10.1055/s-2004-832677.
3
Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.1,3-二邻甲苯基胍、奥匹哌醇和舍曲林(西格玛位点配体)的一些行为效应
Pol J Pharmacol. 1996 Jul-Aug;48(4):379-95.
4
[Opipramol in behavioral pharmacologic anxiety and depression models].[阿丙哌醇在行为药理学焦虑和抑郁模型中的作用]
Fortschr Neurol Psychiatr. 1998 Dec;66 Suppl 1:S17-20. doi: 10.1055/s-2007-1001159.
5
Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.杏仁核基底外侧核的5-HT2C和5-HT1A受体参与慢性抗抑郁治疗的抗焦虑作用。
Neuropharmacology. 2014 Apr;79:127-35. doi: 10.1016/j.neuropharm.2013.11.007. Epub 2013 Nov 22.
6
Alterations in serum and brain trace element levels after antidepressant treatment: part I. Zinc.
Biol Trace Elem Res. 1999 Jan;67(1):85-92. doi: 10.1007/BF02784278.
7
Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.在强迫游泳试验中给予抗抑郁药后以及慢性抗抑郁药治疗后,β-肾上腺素能受体和5-羟色胺2受体的区域特异性神经适应性变化。
J Pharmacol Exp Ther. 1988 Sep;246(3):956-62.
8
Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.用小鼠强迫游泳试验测定某些5-羟色胺受体配体和钙通道拮抗剂的抗抑郁样特性。
Pol J Pharmacol. 1998 Mar-Apr;50(2):117-24.
9
[Postsynaptic attack of tricyclic antidepressive agents in the circulatory system].[三环类抗抑郁药对循环系统的突触后作用]
Acta Biol Med Ger. 1975;34?710:1675-9.
10
Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?Wistar-Kyoto大鼠是对抗抑郁药有抗性的抑郁症基因动物模型吗?
Eur J Pharmacol. 1997 Oct 22;337(2-3):115-23. doi: 10.1016/s0014-2999(97)01276-4.

引用本文的文献

1
The anxiolytic drug opipramol inhibits insulin-induced lipogenesis in fat cells and insulin secretion in pancreatic islets.抗焦虑药物奥匹哌醇可抑制脂肪细胞中胰岛素诱导的脂肪生成和胰岛中胰岛素的分泌。
J Physiol Biochem. 2023 May;79(2):415-425. doi: 10.1007/s13105-023-00950-8. Epub 2023 Feb 23.
2
Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole.Sigma1R 伴侣蛋白参与法莫替唑的抗焦虑作用。
Int J Mol Sci. 2021 May 21;22(11):5455. doi: 10.3390/ijms22115455.
3
Consecutive Controlled Case Series on Effectiveness of Opipramol in Severe Sleep Bruxism Management-Preliminary Study on New Therapeutic Path.
奥匹哌醇治疗重度磨牙症有效性的连续对照病例系列——新治疗途径的初步研究
Brain Sci. 2021 Jan 22;11(2):146. doi: 10.3390/brainsci11020146.
4
Introduction of sustained release opipramol dihydrochloride matrix tablets as a new approach in the treatment of depressive disorders.盐酸奥匹哌醇缓释骨架片作为治疗抑郁症的一种新方法介绍。
Int J Biomed Sci. 2006 Dec;2(4):337-43.
5
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.靶向配体门控分子伴侣 sigma-1 受体治疗神经精神疾病。
Expert Opin Ther Targets. 2011 May;15(5):557-77. doi: 10.1517/14728222.2011.560837. Epub 2011 Mar 5.
6
The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.σ-1拮抗剂BMY-14802通过WAY-100635敏感机制抑制左旋多巴诱导的异常不自主运动。
Psychopharmacology (Berl). 2009 Jul;204(4):743-54. doi: 10.1007/s00213-009-1505-8. Epub 2009 Mar 13.